远程医疗生活方式干预计划TeLIPro在2型糖尿病中改善HbA1c的有效性:现实生活环境中的随机对照试验
Kerstin Kempf1, Clara Dubois2, Matthias Arnold2
1West-German Centre of Diabetes and Health, Düsseldorf Catholic Hospital Group, 40591 Düsseldorf, Germany.
Nutrients
|September 28, 2023
概括
远程医疗生活方式干预计划 (TeLIPro) 改善了2型糖尿病 (T2DM) 患者的HbA1c和生活方式,特别是那些疾病持续时间较长的患者. 这种远程医疗辅导方法在没有配方饮食的情况下显示了现实世界的有效性.
科学领域:
- 内分泌学和新陈代谢学
- 数字健康与远程医疗
- 生活方式 医学 医疗
背景情况:
- 远程医疗生活方式干预计划 (TeLIPro) 已证明在高级2型糖尿病 (T2DM) 中具有有效性.
- 它在改善心脏代谢风险因素,生活质量和通过远程医疗指导改善饮食行为的有效性,没有配方饮食,在现实环境中仍然不太了解.
研究的目的:
- 评估TeLIPro在改善T2DM患者的HbA1c,心脏代谢风险因素,生活质量和饮食行为的有效性.
- 评估远程医疗指导的治疗潜力,作为T2DM管理的常规护理的辅助.
主要方法:
- 一项随机对照试验,涉及1163名由AOK莱兰德/汉堡保险的T2DM患者.
- 参与者接受了例行护理,加上秤,步数计,以及在线门户访问; TeLIPro组额外获得了自我监测血糖设备和远程医疗指导.
- 在基线,6个月和12个月以及6个月的随访期间收集数据;主要终点包括HbA1c变化和正常化率.
主要成果:
- 与单独的常规护理相比,TeLIPro组在HbA1c (ETD-0.4%),体重,BMI,生活质量和饮食行为上显示出显著更大的改善.
- 这些改善在T2DM患者中特别明显,糖尿病持续时间≥5年 (ETD-0.5%).
- 两组之间HbA1c正常化率没有显著差异 (25%对18%).
结论:
- 持续将TeLIPro添加到常规护理中,可以有效地改善T2DM患者的血糖控制 (HbA1c) 和与健康有关的生活方式,特别是那些糖尿病持续时间较长的患者.
- 远程医疗辅导在现实环境中为T2DM管理提供了可行的治疗策略,可以提高患者的治疗结果,而不需要配方饮食.
相关概念视频
Diabetes: Management and Pharmacotherapy
302
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
302
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Carbohydrate Metabolism
11.2K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones
223
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
223


